About 90% of cases of newly diagnosed T1DM have detectable antibodies against specific β-cell proteins, like insulin, insulinoma antigen 2, glutamate decarboxylase, tetraspanin-7, or zinc transporter 8 [11]. The gene discussed is INS; the disease is type 1 diabetes mellitus.